Bradley Foster & Sargent’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Buy
+195,435
New +$24M 0.38% 61
2024
Q4
Sell
-8,582
Closed -$1.28M 474
2024
Q3
$1.28M Buy
8,582
+2,646
+45% +$379K 0.02% 255
2024
Q2
$748K Sell
5,936
-78
-1% -$12.2K 0.01% 306
2024
Q1
$1.11M Buy
6,014
+296
+5% +$56.4K 0.02% 263
2023
Q4
$1.03M Buy
+5,718
New +$890K 0.02% 271

Other funds holding RGEN

Bradley Foster & Sargent's RGEN Position: Q2 2026 in Review

Bradley Foster & Sargent opened a new position in Repligen (RGEN) in Q2 2026: 195,435 shares worth $26.7M. The stake represents 0.38% of the portfolio and ranks #61 among its holdings. This is a return to the name: Bradley Foster & Sargent previously reported a position in RGEN as recently as Q3 2024.

Bradley Foster & Sargent first reported a position in RGEN in Q4 2023 and has held it in 5 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bradley Foster & Sargent held 195,435 shares of Repligen worth $26.7M as of Q2 2026.
  • Repligen was a new Bradley Foster & Sargent position in Q2 2026.
  • Repligen made up 0.38% of Bradley Foster & Sargent's portfolio in Q2 2026, its #61 holding.
  • Bradley Foster & Sargent first reported a position in Repligen in Q4 2023 and has held it in 5 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.